Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial

Vitiligo development in melanoma patients during immunotherapy is a favorable prognostic sign and indicates breakage of tolerance against melanocytic/melanoma antigens. We investigated a novel immunotherapeutic approach of the skin-depigmenting compound monobenzone synergizing with imiquimod in indu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Teulings, Hansje-Eva, Tjin, Esther P. M., Willemsen, Karina J., van der Kleij, Stephanie, ter Meulen, Sylvia, Kemp, E. Helen, Krebbers, Gabrielle, van Noesel, Carel J. M., Franken, Cornelis L. M. C., Drijfhout, Jan W., Melief, Cornelis J. M., Nieuweboer-Krobotova, Ludmila, Nieweg, Omgo E., van der Hage, Jos A., van der Veen, J. P. Wietze, Relyveld, Germaine N., Luiten, Rosalie M.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889200/
https://ncbi.nlm.nih.gov/pubmed/29632737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1419113
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados